Hexedrone

Hexedrone is a stimulant of the substituted cathinone class. Through analysis of the Structure-Activity Relationships in similar cathinones such as MDPV, Hexedrone is believed to be a norepinephrine–dopamine reuptake inhibitor.

Hexedrone
Names
IUPAC name
2-(Methylamino)-1-phenylhexan-1-one
Other names
Hexedrone, HEX
Identifiers
3D model (JSmol)
Properties
C13H18NO
Molar mass 204.293 g·mol−1
Appearance White crystalline solid
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
Infobox references

Subjective effects include stimulation, disinhibition, thought acceleration and euphoria.

Little is known about toxicity, addiction, and abuse potential of hexedrone. Due to its novelty and extremely short history of human usage, all information related to the use of this compound should be treated with caution.

In the UK, Hexedrone is a Class B drug under The Misuse of Drugs Act 1971 (Amendment) Order 2010 following the ACMD's report on substituted cathinone derivatives,[1] making it illegal to sell, buy, or possess without a license.[2][3]

See also

References

  1. "ACMD Consideration of The Cathinones". ACMD. 31 March 2010.
  2. "A change to the Misuse of Drugs Act 1971 : Control of mephedrone and other cathinone derivatives". Home Office. 16 April 2010. Archived from the original on 25 January 2013.CS1 maint: BOT: original-url status unknown (link)
  3. "The Misuse of Drugs Act 1971 (Amendment) Order 2010". Home Office. 12 April 2010.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.